Anthony O. Caggiano,Anindita Ganguly,Jennifer Iaci,Tom Parry
申请号：
US15957122
公开号：
US20180303904A1
申请日:
2018.04.19
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to treatment and prevention of heart failure in a mammal. The invention provides a dosing regimen whereby the therapeutic benefits conferred by administration of peptide comprising an epidermal growth factor-like domain, e.g., a neuregulin such as glial growth factor 2 (GGF2) or a functional fragment thereof, are maintained and/or enhanced, while concomitantly minimizing any potential side effects.
